|
1. US-Iran conflict threatens generic drug supply Full story
2. Drug affordability worries highest since 2018: KFF poll Full story
3. This is a defining moment for oncology — 9 health system leaders share why here.
4. Eli Lilly warns of risks tied to compounded tirzepatide with B12 Full story
5. Clinicians divided amid growing demand for unproven autism drug Full story
6. 340B complexity is rising while staffing stays tight. Align procurement decisions with connected insights here.
7. Kroger pharmacies add Zepbound KwikPen Full story
8. CMS moves forward with 3rd round of Medicare drug negotiations Full story
9. White House moves to temper HHS before midterms: WSJ Full story
10. Winter storm disrupts care in 2 states Full story
11. Oklahoma pharmacy school to expand radiopharmaceutical access with new facility Full story
12. Where pharmacy margin and control slip away inside health systems — and how leaders can respond, here.
Becker's Learning Opportunities
13. How Dartmouth Health links pharmacy performance to financial outcomes here.
14. Health systems are redefining specialty medication access with integrated solutions. Learn how here.
15. Outpatient + specialty pharmacies face new 340B billing challenges. See what's changing here.
16. Interested in more? See Becker’s full lineup of
webinars
and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
